

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to zinc ion (GO:0071294) | 5.67638731 |
| 2 | cellular response to cadmium ion (GO:0071276) | 5.15440329 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.14517174 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00376411 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.57886512 |
| 6 | protein carboxylation (GO:0018214) | 4.57886512 |
| 7 | plasma lipoprotein particle clearance (GO:0034381) | 4.56784522 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.56146328 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.56146328 |
| 10 | low-density lipoprotein particle clearance (GO:0034383) | 4.48219720 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.46371524 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.46371524 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36141925 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 4.31610050 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.29582077 |
| 16 | complement activation, alternative pathway (GO:0006957) | 4.20899746 |
| 17 | urea cycle (GO:0000050) | 4.14127199 |
| 18 | urea metabolic process (GO:0019627) | 4.14127199 |
| 19 | regulation of cholesterol storage (GO:0010885) | 4.10554542 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.08382185 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.08178675 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.07982943 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.07982943 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.07982943 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.05108378 |
| 26 | oligosaccharide catabolic process (GO:0009313) | 4.05057760 |
| 27 | regulation of sequestering of triglyceride (GO:0010889) | 4.04003736 |
| 28 | phospholipid efflux (GO:0033700) | 3.97031515 |
| 29 | bile acid biosynthetic process (GO:0006699) | 3.95243320 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 3.94188680 |
| 31 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.93508341 |
| 32 | tryptophan metabolic process (GO:0006568) | 3.90261857 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 3.89670104 |
| 34 | aldehyde catabolic process (GO:0046185) | 3.87709930 |
| 35 | regulation of protein activation cascade (GO:2000257) | 3.86764337 |
| 36 | reverse cholesterol transport (GO:0043691) | 3.84504315 |
| 37 | cysteine metabolic process (GO:0006534) | 3.83411086 |
| 38 | glyoxylate metabolic process (GO:0046487) | 3.80388420 |
| 39 | regulation of cholesterol homeostasis (GO:2000188) | 3.78928621 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 3.78647259 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.72568304 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.72568304 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72568304 |
| 44 | regulation of fibrinolysis (GO:0051917) | 3.71426028 |
| 45 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.67661992 |
| 46 | regulation of complement activation (GO:0030449) | 3.66632647 |
| 47 | acylglycerol homeostasis (GO:0055090) | 3.61196373 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.61196373 |
| 49 | positive regulation of lipid catabolic process (GO:0050996) | 3.57639457 |
| 50 | positive regulation of extracellular matrix organization (GO:1903055) | 3.56720010 |
| 51 | phospholipid homeostasis (GO:0055091) | 3.55798220 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.54285931 |
| 53 | cholesterol efflux (GO:0033344) | 3.53146740 |
| 54 | L-ascorbic acid metabolic process (GO:0019852) | 3.49358259 |
| 55 | fibrinolysis (GO:0042730) | 3.44063087 |
| 56 | regulation of metalloenzyme activity (GO:0048552) | 3.42742451 |
| 57 | bile acid metabolic process (GO:0008206) | 3.41094035 |
| 58 | plasma lipoprotein particle assembly (GO:0034377) | 3.39606546 |
| 59 | glycosphingolipid catabolic process (GO:0046479) | 3.37313628 |
| 60 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.36658472 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36658472 |
| 62 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.34462729 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.33602991 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.31874785 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.31222816 |
| 66 | positive regulation of cholesterol efflux (GO:0010875) | 3.27881679 |
| 67 | lysine metabolic process (GO:0006553) | 3.24693784 |
| 68 | lysine catabolic process (GO:0006554) | 3.24693784 |
| 69 | ethanol oxidation (GO:0006069) | 3.20510862 |
| 70 | fatty acid oxidation (GO:0019395) | 3.20146849 |
| 71 | lipoprotein metabolic process (GO:0042157) | 3.19911991 |
| 72 | positive regulation of lipid storage (GO:0010884) | 3.18123036 |
| 73 | lipid oxidation (GO:0034440) | 3.16879112 |
| 74 | protein-lipid complex assembly (GO:0065005) | 3.16826367 |
| 75 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.16765766 |
| 76 | COPII vesicle coating (GO:0048208) | 3.16763194 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.16586575 |
| 78 | cholesterol transport (GO:0030301) | 3.15818369 |
| 79 | sterol transport (GO:0015918) | 3.15818369 |
| 80 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13648593 |
| 81 | plasma lipoprotein particle organization (GO:0071827) | 3.13287982 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 3.13167036 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.13167036 |
| 84 | response to thyroid hormone (GO:0097066) | 3.12761717 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.12542054 |
| 86 | acute-phase response (GO:0006953) | 3.12536138 |
| 87 | aromatic amino acid family metabolic process (GO:0009072) | 3.11861934 |
| 88 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11527043 |
| 89 | positive regulation of blood coagulation (GO:0030194) | 3.09271638 |
| 90 | positive regulation of hemostasis (GO:1900048) | 3.09271638 |
| 91 | cofactor catabolic process (GO:0051187) | 3.08757280 |
| 92 | regulation of plasminogen activation (GO:0010755) | 3.08609460 |
| 93 | tyrosine metabolic process (GO:0006570) | 3.07441730 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 3.07155248 |
| 95 | regulation of lipid storage (GO:0010883) | 3.07150201 |
| 96 | fatty acid catabolic process (GO:0009062) | 3.06822452 |
| 97 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.06758579 |
| 98 | glycolipid catabolic process (GO:0019377) | 3.05910719 |
| 99 | serine family amino acid catabolic process (GO:0009071) | 3.05838128 |
| 100 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.05576224 |
| 101 | carnitine metabolic process (GO:0009437) | 3.03564816 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.03305160 |
| 103 | fatty acid transmembrane transport (GO:1902001) | 3.02639342 |
| 104 | protein-lipid complex subunit organization (GO:0071825) | 3.01758753 |
| 105 | positive regulation of coagulation (GO:0050820) | 3.01415735 |
| 106 | sterol homeostasis (GO:0055092) | 3.00851076 |
| 107 | positive regulation of cholesterol transport (GO:0032376) | 3.00550843 |
| 108 | positive regulation of sterol transport (GO:0032373) | 3.00550843 |
| 109 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.99416609 |
| 110 | pinocytosis (GO:0006907) | 2.98290495 |
| 111 | cellular response to arsenic-containing substance (GO:0071243) | 2.97720549 |
| 112 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.97260041 |
| 113 | progesterone metabolic process (GO:0042448) | 2.97103369 |
| 114 | regulation of lipoprotein lipase activity (GO:0051004) | 2.96956143 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 2.96019012 |
| 116 | regulation of cholesterol metabolic process (GO:0090181) | 2.94500379 |
| 117 | negative regulation of protein activation cascade (GO:2000258) | 2.92794596 |
| 118 | negative regulation of lipid storage (GO:0010888) | 2.91568811 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 2.90908985 |
| 120 | valine metabolic process (GO:0006573) | 2.90638931 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90444540 |
| 122 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.90028979 |
| 123 | ceramide catabolic process (GO:0046514) | 2.89860730 |
| 124 | cellular glucuronidation (GO:0052695) | 2.88832737 |
| 125 | peptidyl-proline hydroxylation (GO:0019511) | 2.88645631 |
| 126 | uronic acid metabolic process (GO:0006063) | 2.88153823 |
| 127 | glucuronate metabolic process (GO:0019585) | 2.88153823 |
| 128 | benzene-containing compound metabolic process (GO:0042537) | 2.88123864 |
| 129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.87705157 |
| 130 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.87705157 |
| 131 | negative regulation of coagulation (GO:0050819) | 2.87181432 |
| 132 | regulation of triglyceride metabolic process (GO:0090207) | 2.87164017 |
| 133 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.87096443 |
| 134 | negative regulation of protein autophosphorylation (GO:0031953) | 2.85083058 |
| 135 | alpha-amino acid catabolic process (GO:1901606) | 2.84120472 |
| 136 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82405629 |
| 137 | response to nitrosative stress (GO:0051409) | 2.82297459 |
| 138 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.81999106 |
| 139 | apoptotic cell clearance (GO:0043277) | 2.81087776 |
| 140 | intestinal cholesterol absorption (GO:0030299) | 2.80883133 |
| 141 | negative regulation of blood coagulation (GO:0030195) | 2.80120005 |
| 142 | negative regulation of hemostasis (GO:1900047) | 2.80120005 |
| 143 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.80043018 |
| 144 | protein hydroxylation (GO:0018126) | 2.74898635 |
| 145 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.73772145 |
| 146 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.73231963 |
| 147 | hemoglobin metabolic process (GO:0020027) | 2.70902454 |
| 148 | amino sugar catabolic process (GO:0046348) | 2.69919688 |
| 149 | negative regulation of macrophage differentiation (GO:0045650) | 2.64832165 |
| 150 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.64608677 |
| 151 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.64248160 |
| 152 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.62515591 |
| 153 | negative regulation of lipid transport (GO:0032369) | 2.62139364 |
| 154 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.62125545 |
| 155 | endocrine hormone secretion (GO:0060986) | 2.60330738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.98394724 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.02511542 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.70716280 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.05079789 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.52806292 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.41460342 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.63971217 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.55788020 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.54132583 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.13469447 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.86623394 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67894938 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.60609326 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.56527479 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46930754 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37891453 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30058031 |
| 18 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28559956 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25272350 |
| 20 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16029607 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12736575 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12309390 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11047679 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09929560 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01223005 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.89617247 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88595889 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78554735 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68824023 |
| 30 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65434962 |
| 31 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59096660 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57480158 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56562332 |
| 34 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55254147 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49516569 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47081522 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45910965 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.44749186 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43335447 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41920461 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37617310 |
| 42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.35022100 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30558333 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29075640 |
| 45 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25343593 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23884309 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20669340 |
| 48 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.20528697 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18171568 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15253582 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14747237 |
| 52 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08957492 |
| 53 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07779248 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04016598 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03635295 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03169006 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02757011 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02753813 |
| 59 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01042816 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97520899 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97344601 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96376513 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95470228 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95303435 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95279237 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94456742 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94370549 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93425481 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93425481 |
| 70 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93194498 |
| 71 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93194498 |
| 72 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92488961 |
| 73 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92240556 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91937982 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91889959 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90410431 |
| 77 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.90216901 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89226056 |
| 79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88897629 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88071916 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87985294 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87396087 |
| 83 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85326609 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84607412 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84101220 |
| 86 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84068037 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83556680 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83379502 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83064262 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82750363 |
| 91 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81372760 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81326036 |
| 93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80283390 |
| 94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79553894 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78241097 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77690427 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77557170 |
| 98 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77222782 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77218461 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77202672 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77095056 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76859338 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76859338 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75867271 |
| 105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75639547 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 0.75550126 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.75002792 |
| 108 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74968888 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74704332 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74213271 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73709725 |
| 112 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.73656677 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73489431 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73020410 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72367620 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71391873 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71294119 |
| 118 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70383062 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70311575 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.69611840 |
| 121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.69545670 |
| 122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69420947 |
| 123 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.69254637 |
| 124 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.69018593 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68255686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.36111360 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.70846468 |
| 3 | MP0005360_urolithiasis | 4.64876156 |
| 4 | MP0005365_abnormal_bile_salt | 4.11617452 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.84585115 |
| 6 | MP0009840_abnormal_foam_cell | 3.61883968 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.19978410 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.13814540 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.01331963 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.77182642 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.48326240 |
| 12 | MP0006054_spinal_hemorrhage | 2.46380020 |
| 13 | MP0003252_abnormal_bile_duct | 2.41585519 |
| 14 | MP0005083_abnormal_biliary_tract | 2.39467208 |
| 15 | MP0004272_abnormal_basement_membrane | 2.08471098 |
| 16 | MP0003436_decreased_susceptibility_to | 2.07073202 |
| 17 | MP0005670_abnormal_white_adipose | 2.03492064 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.00417779 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 1.97191781 |
| 20 | MP0003195_calcinosis | 1.96365637 |
| 21 | * MP0000609_abnormal_liver_physiology | 1.95691125 |
| 22 | MP0003186_abnormal_redox_activity | 1.91292006 |
| 23 | MP0005332_abnormal_amino_acid | 1.90437532 |
| 24 | * MP0002118_abnormal_lipid_homeostasis | 1.80365982 |
| 25 | MP0003279_aneurysm | 1.76327361 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.70960344 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.69737595 |
| 28 | MP0003724_increased_susceptibility_to | 1.65726308 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.65591296 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.62601751 |
| 31 | MP0004130_abnormal_muscle_cell | 1.59657578 |
| 32 | * MP0004019_abnormal_vitamin_homeostasis | 1.56912794 |
| 33 | MP0002419_abnormal_innate_immunity | 1.52610015 |
| 34 | MP0006082_CNS_inflammation | 1.51652348 |
| 35 | MP0002254_reproductive_system_inflammat | 1.49853277 |
| 36 | MP0009764_decreased_sensitivity_to | 1.44356162 |
| 37 | MP0009785_altered_susceptibility_to | 1.43099373 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43092236 |
| 39 | MP0003303_peritoneal_inflammation | 1.42505871 |
| 40 | MP0000604_amyloidosis | 1.39288094 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.38245517 |
| 42 | MP0008469_abnormal_protein_level | 1.38144973 |
| 43 | MP0008260_abnormal_autophagy | 1.37308216 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.36042688 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.27775942 |
| 46 | MP0001879_abnormal_lymphatic_vessel | 1.27409863 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.24194792 |
| 48 | MP0000343_altered_response_to | 1.23034680 |
| 49 | MP0001853_heart_inflammation | 1.22178513 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.22032083 |
| 51 | MP0004233_abnormal_muscle_weight | 1.21856701 |
| 52 | MP0002971_abnormal_brown_adipose | 1.21602789 |
| 53 | MP0005025_abnormal_response_to | 1.21160863 |
| 54 | MP0003690_abnormal_glial_cell | 1.20517187 |
| 55 | MP0005451_abnormal_body_composition | 1.19966687 |
| 56 | MP0009763_increased_sensitivity_to | 1.19920876 |
| 57 | MP0001915_intracranial_hemorrhage | 1.17768269 |
| 58 | MP0000598_abnormal_liver_morphology | 1.16146516 |
| 59 | * MP0001881_abnormal_mammary_gland | 1.15932738 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.14614292 |
| 61 | MP0004883_abnormal_blood_vessel | 1.14406467 |
| 62 | MP0002933_joint_inflammation | 1.13759392 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.13264908 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.12801196 |
| 65 | MP0003828_pulmonary_edema | 1.11365556 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.10125442 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.08226373 |
| 68 | MP0001764_abnormal_homeostasis | 1.07301711 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.07236052 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 1.03107195 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.02454278 |
| 72 | MP0004947_skin_inflammation | 1.01233638 |
| 73 | MP0005334_abnormal_fat_pad | 1.00225584 |
| 74 | MP0005000_abnormal_immune_tolerance | 0.97671164 |
| 75 | MP0008004_abnormal_stomach_pH | 0.96880730 |
| 76 | MP0005165_increased_susceptibility_to | 0.96457967 |
| 77 | MP0009697_abnormal_copulation | 0.95093253 |
| 78 | MP0009115_abnormal_fat_cell | 0.94456414 |
| 79 | MP0005164_abnormal_response_to | 0.94328079 |
| 80 | MP0005275_abnormal_skin_tensile | 0.94067150 |
| 81 | MP0005023_abnormal_wound_healing | 0.91716734 |
| 82 | MP0005387_immune_system_phenotype | 0.90969501 |
| 83 | MP0001790_abnormal_immune_system | 0.90969501 |
| 84 | MP0003075_altered_response_to | 0.89370132 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88650900 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.88493068 |
| 87 | MP0000685_abnormal_immune_system | 0.85944429 |
| 88 | MP0002452_abnormal_antigen_presenting | 0.85120654 |
| 89 | MP0003091_abnormal_cell_migration | 0.83933757 |
| 90 | MP0005408_hypopigmentation | 0.81949923 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.81174483 |
| 92 | MP0001756_abnormal_urination | 0.81024594 |
| 93 | MP0001661_extended_life_span | 0.80831218 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.80737765 |
| 95 | MP0003329_amyloid_beta_deposits | 0.79704831 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.79091295 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.78168939 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.77747572 |
| 99 | MP0005166_decreased_susceptibility_to | 0.77561196 |
| 100 | MP0000858_altered_metastatic_potential | 0.74952394 |
| 101 | MP0003448_altered_tumor_morphology | 0.74842095 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 0.73485558 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.73485558 |
| 104 | MP0002060_abnormal_skin_morphology | 0.73168501 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.73009928 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.73001788 |
| 107 | MP0002723_abnormal_immune_serum | 0.72985323 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.72494272 |
| 109 | MP0000249_abnormal_blood_vessel | 0.72334332 |
| 110 | MP0004510_myositis | 0.72314614 |
| 111 | MP0000371_diluted_coat_color | 0.71447357 |
| 112 | MP0002405_respiratory_system_inflammati | 0.70773913 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.70050885 |
| 114 | MP0001800_abnormal_humoral_immune | 0.69651880 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.69317530 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.68834607 |
| 117 | MP0002796_impaired_skin_barrier | 0.68216782 |
| 118 | MP0003868_abnormal_feces_composition | 0.66849783 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.66074265 |
| 120 | MP0002970_abnormal_white_adipose | 0.64554466 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.64543279 |
| 122 | MP0005647_abnormal_sex_gland | 0.63502520 |
| 123 | MP0000920_abnormal_myelination | 0.62942982 |
| 124 | MP0005410_abnormal_fertilization | 0.62865859 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.62345713 |
| 126 | MP0005535_abnormal_body_temperature | 0.62158214 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.62102098 |
| 128 | MP0001243_abnormal_dermal_layer | 0.61632772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.64112849 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.64112849 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.64112849 |
| 4 | Xanthomatosis (HP:0000991) | 5.17500910 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.13832096 |
| 6 | Complement deficiency (HP:0004431) | 4.54972830 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.54495300 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.45744876 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.30848633 |
| 10 | Joint hemorrhage (HP:0005261) | 4.26742682 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.23024438 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.18175408 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.12863853 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.04044292 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99098414 |
| 16 | Myocardial infarction (HP:0001658) | 3.94501690 |
| 17 | Abnormality of complement system (HP:0005339) | 3.80326034 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.72238713 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.65410264 |
| 20 | Epidermoid cyst (HP:0200040) | 3.60391430 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.57793653 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.52015218 |
| 23 | Hypercholesterolemia (HP:0003124) | 3.45961467 |
| 24 | Hyperammonemia (HP:0001987) | 3.45538655 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.39336041 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.33358966 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.18744874 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.13834689 |
| 29 | Axonal loss (HP:0003447) | 3.13554706 |
| 30 | Cholecystitis (HP:0001082) | 3.07379799 |
| 31 | Abnormal gallbladder physiology (HP:0012438) | 3.07379799 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 3.04582955 |
| 33 | Hyperglycinuria (HP:0003108) | 3.02180454 |
| 34 | Glomerulonephritis (HP:0000099) | 2.94834849 |
| 35 | Purpura (HP:0000979) | 2.85519634 |
| 36 | Fat malabsorption (HP:0002630) | 2.84241822 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.84032548 |
| 38 | Ketosis (HP:0001946) | 2.84021655 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83120464 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.81234629 |
| 41 | Nausea (HP:0002018) | 2.81170384 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 2.79404763 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.79404763 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.74617311 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.74311945 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.73994164 |
| 47 | Esophageal varix (HP:0002040) | 2.72083453 |
| 48 | Hyperglycinemia (HP:0002154) | 2.71861094 |
| 49 | Skin nodule (HP:0200036) | 2.70926568 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65684716 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65176041 |
| 52 | Recurrent bacterial skin infections (HP:0005406) | 2.64187523 |
| 53 | Follicular hyperkeratosis (HP:0007502) | 2.64049446 |
| 54 | Nephritis (HP:0000123) | 2.61614650 |
| 55 | Abnormality of methionine metabolism (HP:0010901) | 2.60981113 |
| 56 | Tetraparesis (HP:0002273) | 2.58313989 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.58278216 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.58045990 |
| 59 | Abnormality of glycolysis (HP:0004366) | 2.56830187 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55286402 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.52588425 |
| 62 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.49767228 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.46663027 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.46663027 |
| 65 | Abnormality of iron homeostasis (HP:0011031) | 2.45920266 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.45703102 |
| 67 | Retinal atrophy (HP:0001105) | 2.43714562 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.42114546 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.40868955 |
| 70 | Amyloidosis (HP:0011034) | 2.40691124 |
| 71 | Hypertriglyceridemia (HP:0002155) | 2.40640643 |
| 72 | Gingival bleeding (HP:0000225) | 2.37125259 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.34901487 |
| 74 | Steatorrhea (HP:0002570) | 2.33661303 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.33159407 |
| 76 | Abnormality of the periventricular white matter (HP:0002518) | 2.30510617 |
| 77 | Increased serum ferritin (HP:0003281) | 2.29951697 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.27049568 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27049568 |
| 80 | Dysostosis multiplex (HP:0000943) | 2.26120641 |
| 81 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24366791 |
| 82 | Cervical subluxation (HP:0003308) | 2.23848380 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.21348675 |
| 84 | Menorrhagia (HP:0000132) | 2.19408005 |
| 85 | Hyperbilirubinemia (HP:0002904) | 2.19158082 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15105485 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.15105485 |
| 88 | Spastic diplegia (HP:0001264) | 2.13655469 |
| 89 | Vascular calcification (HP:0004934) | 2.10845240 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.07349803 |
| 91 | Polycythemia (HP:0001901) | 2.07134250 |
| 92 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06123597 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 2.05188568 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 2.04291419 |
| 95 | Spontaneous abortion (HP:0005268) | 2.02982915 |
| 96 | Ovoid vertebral bodies (HP:0003300) | 2.02972738 |
| 97 | Mitral stenosis (HP:0001718) | 2.02326420 |
| 98 | Increased CSF protein (HP:0002922) | 2.01777618 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.01733323 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.00827766 |
| 101 | Pancreatitis (HP:0001733) | 2.00415041 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 1.99307007 |
| 103 | Cardiovascular calcification (HP:0011915) | 1.99171237 |
| 104 | Ketoacidosis (HP:0001993) | 1.97930978 |
| 105 | Mediastinal lymphadenopathy (HP:0100721) | 1.96351393 |
| 106 | Cholelithiasis (HP:0001081) | 1.96040152 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95951010 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95951010 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95951010 |
| 110 | Generalized aminoaciduria (HP:0002909) | 1.95523892 |
| 111 | Peritonitis (HP:0002586) | 1.95170303 |
| 112 | Metaphyseal irregularity (HP:0003025) | 1.93907093 |
| 113 | Asymmetric septal hypertrophy (HP:0001670) | 1.93798525 |
| 114 | Increased mean platelet volume (HP:0011877) | 1.93736767 |
| 115 | Type 1 muscle fiber predominance (HP:0003803) | 1.92331282 |
| 116 | Abnormal gallbladder morphology (HP:0012437) | 1.90483037 |
| 117 | Pathologic fracture (HP:0002756) | 1.90402164 |
| 118 | Myoglobinuria (HP:0002913) | 1.89779668 |
| 119 | Loss of speech (HP:0002371) | 1.89319717 |
| 120 | Abnormality of carpal bone ossification (HP:0006257) | 1.87614510 |
| 121 | Metabolic acidosis (HP:0001942) | 1.86669143 |
| 122 | Conjunctival telangiectasia (HP:0000524) | 1.86562070 |
| 123 | Lethargy (HP:0001254) | 1.84880902 |
| 124 | Metaphyseal dysplasia (HP:0100255) | 1.84819704 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.84754143 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.84754143 |
| 127 | Blue sclerae (HP:0000592) | 1.84667831 |
| 128 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.83703770 |
| 129 | Recurrent skin infections (HP:0001581) | 1.82390002 |
| 130 | Thrombophlebitis (HP:0004418) | 1.82304991 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.81737294 |
| 132 | Beaking of vertebral bodies (HP:0004568) | 1.81722956 |
| 133 | Peripheral demyelination (HP:0011096) | 1.81702206 |
| 134 | Glomerulopathy (HP:0100820) | 1.80643434 |
| 135 | Protrusio acetabuli (HP:0003179) | 1.79384248 |
| 136 | Nuclear cataract (HP:0100018) | 1.76416675 |
| 137 | Spondylolisthesis (HP:0003302) | 1.75173718 |
| 138 | Mesangial abnormality (HP:0001966) | 1.68257930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.06777140 |
| 2 | DDR2 | 3.67902284 |
| 3 | BCKDK | 3.53697443 |
| 4 | TRIB3 | 3.33458129 |
| 5 | STK24 | 2.69674511 |
| 6 | ACVR1B | 2.68249834 |
| 7 | TBK1 | 2.66969658 |
| 8 | SIK1 | 2.52622447 |
| 9 | IRAK3 | 2.51884041 |
| 10 | EIF2AK3 | 2.47256078 |
| 11 | ARAF | 2.41499812 |
| 12 | AKT3 | 2.41219132 |
| 13 | NEK9 | 2.37989010 |
| 14 | TYK2 | 2.37030996 |
| 15 | MAP4K2 | 2.33703169 |
| 16 | FGFR4 | 2.31026988 |
| 17 | TGFBR2 | 2.20118161 |
| 18 | CAMK1D | 2.16255689 |
| 19 | PKN2 | 2.16015286 |
| 20 | PBK | 2.15819398 |
| 21 | MAP3K14 | 2.04996881 |
| 22 | NME2 | 2.03276146 |
| 23 | TAOK3 | 2.01989955 |
| 24 | MST1R | 2.00036818 |
| 25 | ABL2 | 1.81403491 |
| 26 | KIT | 1.65682759 |
| 27 | BLK | 1.62600535 |
| 28 | PIM2 | 1.48207546 |
| 29 | JAK1 | 1.42364894 |
| 30 | PTK6 | 1.39674328 |
| 31 | KDR | 1.37061637 |
| 32 | MAP3K3 | 1.35041027 |
| 33 | MAP2K3 | 1.34414571 |
| 34 | EPHA2 | 1.31712647 |
| 35 | TTN | 1.31445838 |
| 36 | LATS2 | 1.30291948 |
| 37 | MAP4K1 | 1.27872080 |
| 38 | IKBKE | 1.25575879 |
| 39 | BMX | 1.24818496 |
| 40 | RIPK1 | 1.24685355 |
| 41 | NLK | 1.24038787 |
| 42 | EPHB1 | 1.23477210 |
| 43 | LRRK2 | 1.16798862 |
| 44 | ERBB4 | 1.15703105 |
| 45 | PIK3CG | 1.15508307 |
| 46 | FLT3 | 1.15400144 |
| 47 | IKBKB | 1.14850489 |
| 48 | PRPF4B | 1.14371353 |
| 49 | CSK | 1.13095900 |
| 50 | FGFR1 | 1.12128751 |
| 51 | IRAK4 | 1.09954402 |
| 52 | KSR2 | 1.08022509 |
| 53 | MAP3K9 | 1.06938536 |
| 54 | STK10 | 1.06677799 |
| 55 | JAK3 | 1.06518289 |
| 56 | MAP3K11 | 1.06455866 |
| 57 | MET | 1.04914056 |
| 58 | CSF1R | 1.03268634 |
| 59 | JAK2 | 1.02388386 |
| 60 | GRK7 | 1.02058674 |
| 61 | CLK1 | 1.01992656 |
| 62 | RPS6KA4 | 1.00651563 |
| 63 | CDK6 | 1.00065823 |
| 64 | ZAP70 | 0.98892971 |
| 65 | CAMK1G | 0.96006117 |
| 66 | LATS1 | 0.93001142 |
| 67 | BMPR2 | 0.87088374 |
| 68 | MAPK11 | 0.85092738 |
| 69 | MAPKAPK3 | 0.82839960 |
| 70 | TRPM7 | 0.82527835 |
| 71 | EPHA3 | 0.82067180 |
| 72 | BRAF | 0.80853722 |
| 73 | TAOK2 | 0.80659655 |
| 74 | PDGFRB | 0.78281851 |
| 75 | MYLK | 0.78076386 |
| 76 | PRKAA2 | 0.73922411 |
| 77 | CHUK | 0.71932207 |
| 78 | PIK3CA | 0.71275935 |
| 79 | PIM1 | 0.70903724 |
| 80 | ILK | 0.69642106 |
| 81 | PDK1 | 0.69189011 |
| 82 | MAP3K1 | 0.67713545 |
| 83 | PTK2 | 0.67450679 |
| 84 | MOS | 0.67145097 |
| 85 | NEK1 | 0.66918553 |
| 86 | MAP3K12 | 0.66523812 |
| 87 | MAPK12 | 0.64426718 |
| 88 | TESK2 | 0.62049364 |
| 89 | MATK | 0.61711567 |
| 90 | ADRBK2 | 0.60555597 |
| 91 | PAK4 | 0.60513342 |
| 92 | MAP2K1 | 0.59793149 |
| 93 | IRAK1 | 0.59700108 |
| 94 | FRK | 0.59188877 |
| 95 | FER | 0.59101579 |
| 96 | RAF1 | 0.59039832 |
| 97 | ABL1 | 0.58701399 |
| 98 | EGFR | 0.58261361 |
| 99 | PDGFRA | 0.58095672 |
| 100 | STK3 | 0.57976779 |
| 101 | PDK2 | 0.57228634 |
| 102 | GSK3A | 0.53864250 |
| 103 | FGFR3 | 0.53792641 |
| 104 | EIF2AK1 | 0.52753365 |
| 105 | MAP3K5 | 0.52275460 |
| 106 | MAPK4 | 0.51887007 |
| 107 | HCK | 0.51376427 |
| 108 | MST4 | 0.50802232 |
| 109 | IGF1R | 0.49091610 |
| 110 | LYN | 0.47860034 |
| 111 | TESK1 | 0.47201569 |
| 112 | BTK | 0.46784803 |
| 113 | TIE1 | 0.46295755 |
| 114 | AKT2 | 0.45923729 |
| 115 | PDPK1 | 0.45872599 |
| 116 | STK4 | 0.45398368 |
| 117 | PRKCD | 0.44559774 |
| 118 | SGK3 | 0.44469013 |
| 119 | DYRK1B | 0.43675743 |
| 120 | ERBB2 | 0.43231639 |
| 121 | MAP2K2 | 0.42185085 |
| 122 | EIF2AK2 | 0.42033763 |
| 123 | FGR | 0.41881324 |
| 124 | TEC | 0.41418066 |
| 125 | RET | 0.40990915 |
| 126 | MAP3K8 | 0.40926665 |
| 127 | MAP2K6 | 0.39397391 |
| 128 | PRKACG | 0.39222070 |
| 129 | DAPK3 | 0.37799685 |
| 130 | MAP3K13 | 0.37782595 |
| 131 | SYK | 0.37540447 |
| 132 | PAK2 | 0.37361169 |
| 133 | PRKG2 | 0.37094313 |
| 134 | RPS6KA6 | 0.36993100 |
| 135 | GRK6 | 0.36961481 |
| 136 | NUAK1 | 0.36345973 |
| 137 | PDK4 | 0.36233595 |
| 138 | PDK3 | 0.36233595 |
| 139 | CDC42BPA | 0.34405733 |
| 140 | MAPK7 | 0.34060078 |
| 141 | SCYL2 | 0.31974550 |
| 142 | PRKD1 | 0.31943957 |
| 143 | PTK2B | 0.30537459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.63934099 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84440857 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76716410 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75019284 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.74387096 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.73675641 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.70937198 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62750720 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.51030205 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40747838 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.37682315 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30420378 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30030242 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.27672957 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.23176595 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.22804025 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.16440503 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10520488 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.09535278 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80136599 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76844567 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70728801 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69187630 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67509161 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66335747 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65013869 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55050786 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50720741 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48645655 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48331930 |
| 31 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.43637906 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41960477 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33286768 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31866756 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30180521 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29072904 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27137415 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27023770 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24675896 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24499571 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22173488 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19720625 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18045892 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.15350388 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15042389 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12019080 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08133031 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.04402730 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03383623 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99243075 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98778647 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97841133 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 0.95708524 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95309406 |
| 55 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95015765 |
| 56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92126475 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88829714 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88741190 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88437863 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87056017 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86947942 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81097227 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80882912 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80854774 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79758462 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77840454 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76018188 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74950118 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69964754 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.68301270 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.67946503 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66970105 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66626602 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66306148 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65935980 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65319774 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61339029 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60559063 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.60007605 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53910738 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.53476927 |
| 82 | Protein export_Homo sapiens_hsa03060 | 0.52097687 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.51508956 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46890306 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.46594427 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.46117633 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44156620 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43957589 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43921143 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42659990 |
| 91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41696231 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39273769 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.38770305 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38476246 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38172231 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38044792 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37435176 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34903232 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34286591 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33865974 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33111842 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.32573271 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32066439 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28673104 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27851401 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.26592708 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.25862865 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.25262384 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.22834361 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.22640994 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22301932 |
| 112 | Influenza A_Homo sapiens_hsa05164 | 0.20217892 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19428303 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19139004 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.18491607 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16766968 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16761831 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16514331 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.15068080 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.13398648 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.12670715 |

